Oxcarbazepine

Suppliers

Names

[ CAS No. ]:
28721-07-5

[ Name ]:
Oxcarbazepine

[Synonym ]:
10,11-Dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide,Oxacarbazepine
10,11-Dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide Oxacarbazepine
Oxecarb
OXCARBAMAZEPINE
Trileptal
Oxcarbapezine
Ocarbazepine
Oxetol
Aurene
Oxcarbazepine
10-Oxo-10,11-dihydro-dibenzo[b,f]azepine-5-carboxylic acid amide
10,11-Dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide
10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide
10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide
5H-Dibenz[b,f]azepine-5-carboxamide, 10,11-dihydro-10-oxo-
EINECS 249-188-8
OXACARBAZEPINE
MFCD00865307

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Boiling Point ]:
457.2±55.0 °C at 760 mmHg

[ Melting Point ]:
215-216°C

[ Molecular Formula ]:
C15H12N2O2

[ Molecular Weight ]:
252.268

[ Flash Point ]:
230.3±31.5 °C

[ Exact Mass ]:
252.089874

[ PSA ]:
63.40000

[ LogP ]:
1.44

[ Vapour Pressure ]:
0.0±1.1 mmHg at 25°C

[ Index of Refraction ]:
1.662

[ Storage condition ]:
Store at RT

[ Water Solubility ]:
DMSO: ~9 mg/mL

MSDS

Click to get detail MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
HN8445000
CHEMICAL NAME :
5H-Dibenz(b,f)azepine-5-carboxamide, 10,11-dihydro-10-oxo-
CAS REGISTRY NUMBER :
28721-07-5
LAST UPDATED :
199806
DATA ITEMS CITED :
1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
14300 mg/kg
SEX/DURATION :
female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 279,1237,1996

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302

[ Precautionary Statements ]:
P301 + P312 + P330

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xn,F

[ Risk Phrases ]:
22-36-20/21/22-11

[ Safety Phrases ]:
16-36/37

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ RTECS ]:
HN8445000

[ HS Code ]:
2933990090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • Licarbazepine
  • 10-Methoxy Iminostilbene
  • Sodium cyanate
  • 10-Methoxycarbamazepine
  • 10,11-Dihydrocarbamazepine
  • Benzaldehyde
  • Triphosgene
  • Chlorosulfonylisocyanate
  • 5,11-Dihydro-10H-dibenzo[b,f]azepin-10-one
  • ch3cho

DownStream

  • Dibenzazepine-10,11-dione
  • r-10-monohydroxy-dihydro-carbamazepin
  • Eslicarbazepine
  • (11-carbamoyl-5-oxo-6H-benzo[b][1]benzazepin-6-yl) acetate
  • 5,11-Dihydro-10H-dibenzo[b,f]azepin-10-one
  • Licarbazepine

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

Functionalized nanocarrier combined seizure-specific vector with P-glycoprotein modulation property for antiepileptic drug delivery.

Biomaterials 74 , 64-76, (2015)

Despite optimal therapeutic regimen with currently available antiepileptic drugs (AEDs), approximately a third of epilepsy patients remain drug refractory. Region-specific overexpression of multidrug ...

Development of a SPE-HPLC-MS/MS method for the determination of most prescribed pharmaceuticals and related metabolites in urban sewage samples.

J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 990 , 23-30, (2015)

Based on regional prescription data several pharmaceuticals with variable amounts of prescription and corresponding metabolites were selected and analyzed in influent and effluent samples of the sewag...

Enhanced brain delivery of lamotrigine with Pluronic(®) P123-based nanocarrier.

Int. J. Nanomedicine 9 , 3923-35, (2014)

P-glycoprotein (P-gp) mediated drug efflux across the blood-brain barrier (BBB) is an important mechanism underlying poor brain penetration of certain antiepileptic drugs (AEDs). Nanomaterials, as dru...


More Articles

Related Compounds

  • Oxcarbazepine-d4
  • Oxcarbazepine-D4
  • 11-Keto Oxcarbazepine
  • N-Formyl Oxcarbazepine
  • 10-Bromo-Oxcarbazepine
  • Oxcarbazepine N-Sulfate
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • 2-(3-{[2-(Tert-butoxy)-2-oxoethoxy]methyl}-5-iodo-4-methylphenyl)acetic acid
  • [4-(4,4-Difluoropiperidin-1-yl)pyrimidin-2-yl]methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4-(3-Amino-1-ethylpiperidin-3-yl)-1-methylpiperidin-4-ol
  • Ethanol, 2,2'-[[p-[(4-chloro-2-methoxyphenyl)azo]phenyl]imino]di-(7CI,8CI)